Prosecution Insights
Last updated: May 29, 2026

Examiner: PAPCIAK, SHARON M

Tech Center 1600 • Art Units: 1651 1657

This examiner grants 50% of resolved cases

Performance Statistics

49.6%
Allow Rate
-10.4% vs TC avg
564
Total Applications
+22.3%
Interview Lift
1156
Avg Prosecution Days
Based on 522 resolved cases, 2023–2026

Rejection Statute Breakdown

2.9%
§101 Eligibility
2.9%
§102 Novelty
74.0%
§103 Obviousness
2.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16975955 COMPOSITIONS OF PARP14 MODULATORS AND/OR MUTANTS AND THERAPEUTIC USE THEREOF Non-Final OA President and Fellows of Harvard College
18484359 METHODS OF INCREASING BIOMASS PRODUCTIVITY IN ALGAE CULTURES Final Rejection Arizona Board of Regents on Behalf of Arizona State University
18431638 COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS Non-Final OA THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
17759864 REGULATION OF POST-ISCHEMIC INFLAMMATORY RESPONSE: A FUNCTION OF TYROSINE PHOSPHATASE STEP Non-Final OA UNM Rainforest Innovations
16973453 Polyesterase II Final Rejection Henkel AG & Co. KGaA
18323672 PAN DOMAIN ACTIVATES UBIQUITINATION Non-Final OA UT-Battelle, LLC
18735583 PROBIOTIC (Bacillus subtilis) SUPPLEMENTATION FOR IMPROVEMENT OF BODY COMPOSITION IN FEMALE ATHLETES Final Rejection Deerland Enzymes, Inc.
18029590 New Granules for Animal Feed Final Rejection Novozymes A/S
18606866 INTESTINAL MICROBIOTA AND GVHD Final Rejection Memorial Sloan-Kettering Cancer Center
18267943 Sialyltransferases for the Production of 6'-Sialyllactose Non-Final OA Chr. Hansen A/S
18416244 ISOLATED DISCOGENIC CELLS, METHODS OF USING, AND METHODS OF PREPARING SAME FROM MAMMALIAN TISSUE Final Rejection DiscGenics, Inc.
18263833 PROTEIN-BASED MATERIAL FOR BIOCATALYSIS Non-Final OA Bondwell Technologies LP
18274539 METHOD FOR PREDICTING OBESITY Non-Final OA Anicom Holdings, Inc.
17292169 METHOD FOR PRODUCING RARE SUGAR-CONTAINING COMPOSITION AND RARE SUGAR-CONTAINING COMPOSITION Final Rejection NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
18037300 METHOD AND DRUG FOR INCREASING NGF LEVEL Non-Final OA Talengen International Limited
18317422 MODULATION OF FUSOBACTERIUM VARIUM TO PREVENT BOVINE LIVER ABSCESSES AND IMPROVE CATTLE PERFORMANCE Non-Final OA Dr. Jacques Mathieu
18031613 Adenosine-Involved Fully Enzymatic Synthesis Method for NMN Final Rejection RUBYBERRIES BIOTECHNOLOGIES CO., LTD
18029110 REAGENT FOR DETECTING LIPOPROTEIN PARTICLE CONCENTRATION AND USING METHOD THEREOF Final Rejection MEDICAL SYSTEM BIOTECHNOLOGY CO., LTD.
17049301 MODIFIED MITOCHONDRIA AND USE THEREOF Final Rejection PAEAN BIOTECHNOLOGY INC.
18115752 COMPOSITION OF LACTIC BACTERIA FOR USE IN THE TREATMENT OF INFECTIONS DUE TO PROPIONIBACTERIUM ACNES AND IN PARTICULAR FOR ACNE Final Rejection Probiotical S.p.A.
17999955 MODIFIED STRAINS OF CHLORELLA VULGARIS AND METHOD OF PRODUCTION Final Rejection ALGENUITY HOLDINGS LTD
17295949 MODIFIED STRAINS OF CHLORELLA VULGARIS AND METHOD OF PRODUCTION Final Rejection ALGENUITY HOLDINGS LTD
17917103 A METHOD AND A SYSTEM FOR DETERMINING SUSCEPTIBILITY Final Rejection Pro Devices A/S
17576722 COMPOSITIONS AND METHODS OF PROMOTING CELLULAR HYDRATION Final Rejection Eastpond Laboratories Limited
17665113 USE OF HIGH QUALITY PROTEIN CONCENTRATE AS AN ANTIBACTERIAL FOR SHELLFISH Non-Final OA Prairie AquaTech LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month